The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Citalopram 40mg/ml Oral Drops, solution



Focus Pharmaceuticals LtdPA1338/003/001

Main Information

Trade NameCitalopram 40mg/ml Oral Drops, solution
Active SubstancesCitalopram hydrochloride
Dosage FormOral drops, solution
Licence HolderFocus Pharmaceuticals Ltd
Licence NumberPA1338/003/001

Group Information

ATC CodeN06AB Selective serotonin reuptake inhibitors
N06AB04 citalopram

Status

License statusWithdrawn
Withdrawn Date17/12/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0073-132-049
Interchangeable List DocumentPDF of Interchangeable List
« Back